1
/
of
0
FDA Drug/Biologics Approval BLA 125514 S-045, PEMBROLIZUMAB
FDA Drug/Biologics Approval BLA 125514 S-045, PEMBROLIZUMAB
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
BLA 125514 S-045
Company: MERCK SHARP DOHME
Drug Name: KEYTRUDA
Active Ingredients: PEMBROLIZUMAB
Strength: 100MG/4ML (25MG/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 09/04/2014
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: MERCK SHARP DOHME
Drug Name: KEYTRUDA
Active Ingredients: PEMBROLIZUMAB
Strength: 100MG/4ML (25MG/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 09/04/2014
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details